| Accession Number: | 0001179110-14-013437 |
| Date: | 2014-08-27 |
| Issuer: | SUNESIS PHARMACEUTICALS INC (SNSS) |
| Original Submission Date: |
CRAIG ADAM R
C/O SUNESIS PHARMACEUTICALS, INC.
395 OYSTER PT. BLVD., STE. 400
SOUTH SAN FRANCISCO, CA 94080
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2014-08-27 | S | 2,554 | d | $8.00 | 12,723 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on july 21, 2014. |
